Literature DB >> 16971405

Genetic determinants of C-reactive protein in COPD.

C P Hersh1, D T Miller, D J Kwiatkowski, E K Silverman.   

Abstract

Chronic obstructive pulmonary disease (COPD) is associated with a systemic inflammatory state, marked by elevations in serum inflammatory markers including C-reactive protein (CRP). The present study sought to determine epidemiological predictors of CRP levels, to estimate the genetic influence on CRP levels, and to identify genetic variants that affect CRP in a family-based study of COPD. CRP was measured by a high-sensitivity assay in participants from the Boston Early-Onset COPD Study. Predictors of CRP level were determined using multilevel linear models. Variance component analysis was used to estimate heritability and to perform genome-wide linkage analysis for CRP levels. Two variants in the surfactant protein B (SFTPB) gene were tested for association with CRP levels. Increased age, female sex, higher body mass index, greater smoking pack-yrs and reduced forced expiratory volume in one second were all associated with increased CRP levels. There was a significant genetic influence on CRP (heritability = 0.25). Genome-wide linkage analysis revealed several potentially interesting chromosomal regions, though no significant evidence for linkage was found. A short tandem repeat marker near SFTPB was significantly associated with CRP levels. There is a genetic influence on C-reactive protein levels in chronic obstructive pulmonary disease patients. Preliminary evidence suggests an association of the surfactant protein B gene with systemic inflammation in chronic obstructive pulmonary disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16971405     DOI: 10.1183/09031936.00147805

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  8 in total

1.  Familial aggregation of circulating C-reactive protein in polycystic ovary syndrome.

Authors:  Arunachalam Sasidevi; Priyathama Vellanki; Allen R Kunselman; Nazia Raja-Khan; Andrea Dunaif; Richard S Legro
Journal:  Hum Reprod       Date:  2012-12-20       Impact factor: 6.918

2.  [The role of counterinsular hormones in the regulation of glucose homeostasis and the pathogenesis of type 2 diabetes mellitus in COPD].

Authors:  V I Kobylyansky
Journal:  Probl Endokrinol (Mosk)       Date:  2021-02-17

3.  C-reactive protein levels in stable COPD patients: a case-control study.

Authors:  Denise Rossato Silva; Marcelo Basso Gazzana; Marli Maria Knorst
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-08-31

4.  Risk of chronic obstructive pulmonary disease in healthy individuals with high C-reactive protein levels by smoking status: a population-based cohort study in Korea.

Authors:  Seong Yong Lim; Di Zhao; Eliseo Guallar; Yoosoo Chang; Seungho Ryu; Juhee Cho; Jung Yeon Shim
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-09-03

Review 5.  Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony.

Authors:  Aibek E Mirrakhimov
Journal:  Cardiovasc Diabetol       Date:  2012-10-27       Impact factor: 9.951

6.  IL6 and CRP haplotypes are associated with COPD risk and systemic inflammation: a case-control study.

Authors:  Dilyara G Yanbaeva; Mieke A Dentener; Martijn A Spruit; Jeanine J Houwing-Duistermaat; Daniel Kotz; Valéria Lima Passos; Emiel F M Wouters
Journal:  BMC Med Genet       Date:  2009-03-09       Impact factor: 2.103

7.  Gender differences in the association between C-reactive protein, lung function impairment, and COPD.

Authors:  Inga Sif Olafsdóttir; Thórarinn Gíslason; Bjarni Thjódleifsson; Isleifur Olafsson; Davíd Gíslason; Rain Jõgi; Christer Janson
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

Review 8.  Surfactant protein D, Club cell protein 16, Pulmonary and activation-regulated chemokine, C-reactive protein, and Fibrinogen biomarker variation in chronic obstructive lung disease.

Authors:  Sofie Lock-Johansson; Jørgen Vestbo; Grith Lykke Sorensen
Journal:  Respir Res       Date:  2014-11-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.